603235 天新药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.43611.47920.85348.56371.640
总资产报酬率 ROA (%)2.8549.74116.30225.38331.792
投入资产回报率 ROIC (%)3.27711.24519.44338.66755.291

边际利润分析
销售毛利率 (%)40.07438.27237.22543.25154.280
营业利润率 (%)35.66629.87431.48634.75945.735
息税前利润/营业总收入 (%)30.33524.58827.56036.06149.231
净利润/营业总收入 (%)29.83825.28526.99229.49138.509

收益指标分析
经营活动净收益/利润总额(%)93.86692.31391.24695.35591.735
价值变动净收益/利润总额(%)0.2080.3671.511-0.7570.805
营业外收支净额/利润总额(%)-0.3590.5220.009-0.390-0.651

偿债能力分析
流动比率 (X)6.3606.76610.1752.3331.105
速动比率 (X)5.5065.7288.6631.7340.883
资产负债率 (%)17.05016.84113.29035.34860.299
带息债务/全部投入资本 (%)-2.355-5.832-6.8322.63210.286
股东权益/带息债务 (%)-3,992.722-1,659.567-1,452.4163,139.465730.187
股东权益/负债合计 (%)486.517493.804652.428182.90165.840
利息保障倍数 (X)-5.829-4.518-7.01325.09112.984

营运能力分析
应收账款周转天数 (天)44.84346.59346.22738.78834.454
存货周转天数 (天)138.704147.134109.00492.540102.118